Etanercept plus methylprednisolone as initial therapy for acute graft-versus-host disease

Graft-versus-host disease (GVHD) is a principal cause of morbidity following allogeneic hematopoietic cell transplantation (HCT). Standard therapy for GVHD, high-dose steroids, results in complete responses (CRs) in 35% of patients. Because tumor necrosis factor-α (TNFα) is an important effector of...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Levine, John E., Paczesny, Sophie, Mineishi, Shin, Braun, Thomas, Choi, Sung W., Hutchinson, Raymond J., Jones, Dawn, Khaled, Yasser, Kitko, Carrie L., Bickley, Daniel, Krijanovski, Oleg, Reddy, Pavan, Yanik, Gregory, Ferrara, James L. M.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society of Hematology 2008
Aiheet:
Transplantation
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2361693/
https://ncbi.nlm.nih.gov/pubmed/18042798
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2007-09-112987
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia